| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCB.21374 |
| P698 | PubMed publication ID | 17520664 |
| P2093 | author name string | Tao Wei | |
| T John Martin | |||
| David L Halladay | |||
| Henry U Bryant | |||
| Jude E Onyia | |||
| Nalini H Kulkarni | |||
| Richard E Higgs | |||
| Yanfei L Ma | |||
| Amar Kumar | |||
| Ernst R Dow | |||
| Jianyong Shou | |||
| Trent R Stewart | |||
| Bruce D Gitter | |||
| Thomas A Engler | |||
| Diane L Sterchi | |||
| Mathias N'cho | |||
| P2860 | cites work | Quantitative histological data on disuse osteoporosis: comparison with biological data | Q34210550 |
| P433 | issue | 6 | |
| P921 | main subject | adipocyte | Q357519 |
| osteoblast | Q917177 | ||
| P304 | page(s) | 1504-1518 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor. | |
| P478 | volume | 102 |
| Q51517961 | A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone. |
| Q43608666 | A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action. |
| Q28581617 | Antagonist minigenes identify genes regulated by parathyroid hormone through G protein-selective and G protein co-regulated mechanisms in osteoblastic cells |
| Q91521103 | Antiresorptive and anabolic agents in the prevention and reversal of bone fragility |
| Q36527849 | Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects |
| Q46900013 | Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody |
| Q34750140 | Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women |
| Q44050826 | Endocrine regulation of bone and energy metabolism in hibernating mammals |
| Q39688886 | Engineered cell-free scaffold with two-stage delivery of miRNA-26a for bone repair |
| Q47142933 | Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing |
| Q47849212 | Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism |
| Q50427151 | Inactivation of glycogen synthase kinase-3β up-regulates β-catenin and promotes chondrogenesis |
| Q35825410 | Osteoporotic fracture and parathyroid hormone |
| Q54408272 | PLS and shape-based similarity analysis of maleimides--GSK-3 inhibitors. |
| Q57791470 | Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton |
| Q41969070 | Protein kinase inhibitor γ reciprocally regulates osteoblast and adipocyte differentiation by downregulating leukemia inhibitory factor |
| Q33520403 | RAGE supports parathyroid hormone-induced gains in femoral trabecular bone |
| Q37109247 | Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis |
| Q39795061 | RhoB enhances migration and MMP1 expression of prostate cancer DU145. |
| Q47411533 | Scaffold-Based microRNA Therapies in Regenerative Medicine and Cancer |
| Q35578733 | Serum bone alkaline phosphatase in assessing illness severity of infected neonates in the neonatal intensive care unit |
| Q35603128 | Targeting bone as a therapy for myeloma. |
| Q37479050 | Targeting the Wnt signaling pathway to augment bone formation |
| Q35915566 | Teriparatide (1-34 human PTH) regulation of osterix during fracture repair |
| Q33685135 | The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells |
| Q39356695 | The roles of signaling pathways in bone repair and regeneration |
| Q83588890 | Wnt signaling as a therapeutic target for bone diseases |
| Q37561706 | Wnt signaling during fracture repair |
| Q36638647 | Wnt signaling in bone formation and its therapeutic potential for bone diseases |
Search more.